Form 8-K - Current report:
SEC Accession No. 0001104659-23-038718
Filing Date
2023-03-30
Accepted
2023-03-30 07:06:36
Documents
14
Period of Report
2023-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310752d4_8k.htm   iXBRL 8-K 28923
2 EXHIBIT 99.1 tm2310752d4_ex99-1.htm EX-99.1 103949
6 GRAPHIC tm2310572d4_ex99-1img001.jpg GRAPHIC 7306
  Complete submission text file 0001104659-23-038718.txt   330055

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20230330.xsd EX-101.SCH 3085
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20230330_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20230330_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310752d4_8k_htm.xml XML 3477
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 23777128
SIC: 2834 Pharmaceutical Preparations